Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Jain Group of Institutions launch Master’s in Political Science and International Relations Press Release
  • 5th International Convention in Delhi with 81 Countries and 29 States participating organised by Vishwa Sindhi Seva Sangam (VSSS) Press Release
  • Manastha: India’s Best Online Psychologist & Psychiatrist Consultation Platform Lifestyle
  • Meet 20 Influential Personalities Who Are Breaking Barriers and Shaping the Future in 2023 Business
  • Steel Exchange India Limited Has Strengthened Its Capital Base Through an Upfront INR 75 Crore Infusion by Allotting Convertible Warrants Business
  • The Memory Shortage Nobody Warned Consumers About Is Finally Here Technology
  • MoGo ESports Private Limited signs winners of MoGo National Championship at a record price Business
  • Bengaluru Boy’s Remarkable Comeback: Mithun Chakravarthy’s Unwavering Comeback Redefines Cricketing Resilience Press Release

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Sterling Hospitals’ Sindhubhavan Unit Spearheads Major Cancer Awareness Walkathon with Rotary Club Health
  • Dietitian Amandeep Soni Empowers Health Journeys Through Singh Nutri Diet Health
  • Dr. Ravul Jindal: A Global Leader Bridging Healthcare and Humanity Health
  • Peerless Hospital Performs First TAVR Procedure, Giving New Lease of Life to Elderly Patient Health
  • How Spine Surgeons Are Helping Shape the Future of India Health
  • IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India Health

Recent Posts

  • Beyond Kibble: A Quiet Bet on Clinical Pet Nutrition Is Reshaping India’s D2C Wellness Map
  • GIFT City Is Not a Tax Shelter. It Is a Tax Architecture. And the Difference Matters.
  • Building for the Long Term: Nimbus Group’s Play in a Maturing NCR Market
  • ABBS School of Management Signs Landmark Study Abroad Agreement with ESCE International Business School, Paris
  • Steel Exchange India Secures 5-Year Renewal of Approval from MES under the Ministry of Defence

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Fraganta by Leena Jain Unveils Its Debut Perfume Pair – Ganga and Jogi – A Revolutionary Ode to Indian Luxury Business
  • Excelia purchases the premises of its Paris-Cachan campus, further consolidating the development of its Paris-based operations Business
  • Protyze Launches Hydra Clear Whey Protein: India’s First Protein-Electrolyte Functional Protein Drink Health
  • Floating Man of India Taking Kashmir’s Tourism To Next Level Lifestyle
  • Khateeb Study Abroad is Helping Students Make Their Way into the Global Educational Prospect Press Release
  • Grt Hotels and Resorts Launches Grand Vijayawada By Grt Hotels Business
  • The Rising Need for Insurance in Gated Communities in India – Ethika Leads the Way Forward Business
  • In a historic first, India’s Neil Aryan Thakur becomes the first Asian to win Mr. Pacific Universe title Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme